ATTEC-mediated degradation of BCR-ABL in chronic myeloid leukemia cells
Year: 2025
Type: article
Language: en
Topic: Chronic Myeloid Leukemia Treatments
Authors and affiliations:
raw_author_name: Zhiyan Wang
raw_affiliation_strings: Department of Molecular Pharmacology, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China; State Key Laboratory of Synthetic Biology and Frontiers Science Center for Synthetic Biology, Tianjin Key Laboratory for Modern Drug Delivery & High-Efficiency, School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin, China
raw_author_name: Tingting Xu
raw_affiliation_strings: State Key Laboratory of Synthetic Biology and Frontiers Science Center for Synthetic Biology, Tianjin Key Laboratory for Modern Drug Delivery & High-Efficiency, School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin, China
raw_author_name: Yiying Che
raw_affiliation_strings: State Key Laboratory of Synthetic Biology and Frontiers Science Center for Synthetic Biology, Tianjin Key Laboratory for Modern Drug Delivery & High-Efficiency, School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin, China
raw_author_name: Jun-An Ma
raw_affiliation_strings: Department of Chemistry, State Key Laboratory Synthetic Biology, Tianjin University, Tianjin, 300072, China
raw_author_name: Runqi Jin
raw_affiliation_strings: State Key Laboratory of Synthetic Biology and Frontiers Science Center for Synthetic Biology, Tianjin Key Laboratory for Modern Drug Delivery & High-Efficiency, School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin, China
raw_author_name: Boao Mao
raw_affiliation_strings: State Key Laboratory of Synthetic Biology and Frontiers Science Center for Synthetic Biology, Tianjin Key Laboratory for Modern Drug Delivery & High-Efficiency, School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin, China
raw_author_name: Xinru Lai
raw_affiliation_strings: State Key Laboratory of Synthetic Biology and Frontiers Science Center for Synthetic Biology, Tianjin Key Laboratory for Modern Drug Delivery & High-Efficiency, School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin, China
raw_author_name: Kunrong Mei
raw_affiliation_strings: State Key Laboratory of Synthetic Biology and Frontiers Science Center for Synthetic Biology, Tianjin Key Laboratory for Modern Drug Delivery & High-Efficiency, School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin, China. Electronic address: kmei@tju.edu.cn
raw_author_name: Hongxia Zhao
raw_affiliation_strings: State Key Laboratory of Synthetic Biology and Frontiers Science Center for Synthetic Biology, Tianjin Key Laboratory for Modern Drug Delivery & High-Efficiency, School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin, China. Electronic address: zhaohongxia@tju.edu.cn
raw_author_name: Zhiguang Yuchi
raw_affiliation_strings: Department of Molecular Pharmacology, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China; State Key Laboratory of Synthetic Biology and Frontiers Science Center for Synthetic Biology, Tianjin Key Laboratory for Modern Drug Delivery & High-Efficiency, School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin, China; Haihe Laboratory of Sustainable Chemical Transformations, Tianjin, China. Electronic address: yuchi@tju.edu.cn